Discover Shionogi & Co Ltd's innovative patent for a minimally colored solid preparation, enhancing stability and release with light-stabilizing substances and specific compounds.
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...
The company’s lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease ...
Amelia Ti is a Registered Dietitian (RD) and Certified Diabetes Care and Education Specialist (CDCES) based in NYC. She completed her Bachelor's in Nutrition & Dietetics at NYU and Master's in ...
The drug and any additional excipients are uniformly blended with a hydrophilic polymer (hydroxypropyl methylcellulose) and then compressed into tablets. Upon ingestion, GI fluid penetrates the ...